Havih has entered into a strategic partnership with US-based Maxwell Biosciences to collaborate on advanced biotechnology and pharmaceutical research initiatives. 

The partnership is expected to focus on innovation-driven drug discovery and therapeutic development. 

It reflects increasing cross-border collaboration between Indian and US life sciences firms. 

Such alliances enhance technology transfer and research capabilities within India. 

The move also supports India’s ambition to become a global biotech innovation hub.